DE69729392D1 - Antikonvulsive enantiomerische Aminosäurederivate - Google Patents

Antikonvulsive enantiomerische Aminosäurederivate

Info

Publication number
DE69729392D1
DE69729392D1 DE69729392T DE69729392T DE69729392D1 DE 69729392 D1 DE69729392 D1 DE 69729392D1 DE 69729392 T DE69729392 T DE 69729392T DE 69729392 T DE69729392 T DE 69729392T DE 69729392 D1 DE69729392 D1 DE 69729392D1
Authority
DE
Germany
Prior art keywords
anticonvulsant
amino acid
acid derivatives
enantiomeric amino
animal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69729392T
Other languages
English (en)
Other versions
DE69729392T2 (de
Inventor
Harold Kohn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Research Corp Technologies Inc
Original Assignee
Research Corp Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21760388&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69729392(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Research Corp Technologies Inc filed Critical Research Corp Technologies Inc
Application granted granted Critical
Publication of DE69729392D1 publication Critical patent/DE69729392D1/de
Publication of DE69729392T2 publication Critical patent/DE69729392T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69729392T 1996-03-15 1997-03-17 Krampfhemmende enantiomere Aminosäurederivate Expired - Lifetime DE69729392T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1352296P 1996-03-15 1996-03-15
US13522P 1996-03-15

Publications (2)

Publication Number Publication Date
DE69729392D1 true DE69729392D1 (de) 2004-07-08
DE69729392T2 DE69729392T2 (de) 2005-06-02

Family

ID=21760388

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69729392T Expired - Lifetime DE69729392T2 (de) 1996-03-15 1997-03-17 Krampfhemmende enantiomere Aminosäurederivate
DE69705210T Expired - Lifetime DE69705210T2 (de) 1996-03-15 1997-03-17 Krampflösende, enantiomere aminosäure-derivate
DE122009000010C Active DE122009000010I2 (de) 1996-03-15 1997-03-17 Krampflösende, enantiomere aminosäure-derivate

Family Applications After (2)

Application Number Title Priority Date Filing Date
DE69705210T Expired - Lifetime DE69705210T2 (de) 1996-03-15 1997-03-17 Krampflösende, enantiomere aminosäure-derivate
DE122009000010C Active DE122009000010I2 (de) 1996-03-15 1997-03-17 Krampflösende, enantiomere aminosäure-derivate

Country Status (12)

Country Link
EP (2) EP1038522B1 (de)
JP (1) JP3145414B2 (de)
AT (2) ATE268169T1 (de)
AU (1) AU718577B2 (de)
CA (1) CA2248317C (de)
DE (3) DE69729392T2 (de)
DK (2) DK0888289T3 (de)
ES (2) ES2218024T3 (de)
FR (1) FR09C0006I2 (de)
NL (1) NL300376I1 (de)
PT (2) PT1038522E (de)
WO (1) WO1997033861A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6048899A (en) * 1997-03-17 2000-04-11 Research Corporation Tech., Inc. Anticonvulsant enantiomeric amino acid derivatives
EP1642889A1 (de) * 2004-10-02 2006-04-05 Schwarz Pharma Ag Verbessertes Syntheseschema für Lacosamid
EP1873527A1 (de) 2006-06-30 2008-01-02 Schwarz Pharma Ag Verfahren zur Identifizierung von CRMP-Modulatoren
US8093426B2 (en) 2007-12-04 2012-01-10 Ranbaxy Laboratories Limited Intermediate compounds and their use in preparation of lacosamide
DE102008059155A1 (de) 2008-11-27 2010-06-02 Ratiopharm Gmbh Trockenverarbeitung und neue Formen von Lacosamid
WO2011015617A1 (en) 2009-08-06 2011-02-10 Medichem, S.A. Solid forms of an n-(phenylmethyl)propanamide derivative and processes of preparation
WO2011039781A1 (en) * 2009-09-25 2011-04-07 Cadila Healthcare Limited Processes for the preparation of lacosamide and intermediates thereof
IT1398044B1 (it) * 2010-01-29 2013-02-07 Archimica Srl Processo per la preparazione della lacosamide
KR20120128667A (ko) 2010-02-08 2012-11-27 낫코 파마 리미티드 라코사미드의 제조방법
WO2011099033A1 (en) * 2010-02-09 2011-08-18 Msn Laboratories Limited Process for preparing (r)-2-acetamido-n-benzyl-3-methoxy-propionamide
EP2399901A1 (de) 2010-06-23 2011-12-28 Archimica GmbH Zwischenprodukt zur Herstellung von Lacosamid und Verfahren zu dessen Herstellung und Umwandlung zu Lacosamid
EP2621893A1 (de) 2010-10-01 2013-08-07 UCB Pharma GmbH Verfahren zur herstellung von aminosäurederivaten
EP2627639B1 (de) * 2010-10-15 2021-12-22 Nektar Therapeutics N-optional substituierte aryl-2-oligomer-3-alkoxypropionamides
ES2619403T3 (es) 2010-10-19 2017-06-26 Euticals Gmbh Proceso para producir lacosamida
EP2468261A1 (de) 2010-12-02 2012-06-27 UCB Pharma GmbH Formulierung von Lacosamid
CA2817654A1 (en) 2010-12-02 2012-06-07 Ucb Pharma Gmbh Once daily formulation of lacosamide
CN104771356A (zh) * 2014-01-09 2015-07-15 山东方明药业集团股份有限公司 一种拉科酰胺注射液及其制备方法
US11278634B1 (en) 2021-02-12 2022-03-22 Extrovis Ag Stable parenteral composition of lacosamide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378729A (en) * 1985-02-15 1995-01-03 Research Corporation Technologies, Inc. Amino acid derivative anticonvulsant
ATE62222T1 (de) * 1985-02-15 1991-04-15 Res Corp Technologies Inc Aminosaeure-derivate und ihre anwendung zur herstellung eines antikrampfmittels.

Also Published As

Publication number Publication date
DE69705210T2 (de) 2001-09-20
CA2248317A1 (en) 1997-09-18
DE69705210D1 (de) 2001-07-19
AU2539497A (en) 1997-10-01
ES2218024T3 (es) 2004-11-16
DK0888289T3 (da) 2001-09-03
AU718577B2 (en) 2000-04-13
ATE268169T1 (de) 2004-06-15
FR09C0006I2 (fr) 2009-12-18
ATE202079T1 (de) 2001-06-15
JP2000505476A (ja) 2000-05-09
EP0888289B1 (de) 2001-06-13
ES2157567T3 (es) 2001-08-16
PT888289E (pt) 2001-09-28
DE69729392T2 (de) 2005-06-02
DE122009000010I1 (de) 2009-05-20
DK1038522T3 (da) 2004-10-11
NL300376I1 (nl) 2009-05-06
DE122009000010I2 (de) 2010-10-21
CA2248317C (en) 2003-12-02
JP3145414B2 (ja) 2001-03-12
WO1997033861A1 (en) 1997-09-18
EP0888289A1 (de) 1999-01-07
EP1038522A3 (de) 2003-01-15
PT1038522E (pt) 2004-10-29
EP1038522B1 (de) 2004-06-02
FR09C0006I1 (de) 2009-04-17
EP1038522A2 (de) 2000-09-27

Similar Documents

Publication Publication Date Title
NL300376I1 (nl) Enantiomere anticonvulsieaminozuurderivaten
DK0616807T3 (da) Benzimidazol anvendelig i behandlingen af forstyrrelser i centralnervesystemet
PT1004578E (pt) Derivados hidroxamida do acido 5-oxo-pirrolidino-2-carboxilico
BR9808281A (pt) Compostos, composições farmacêuticas, processo para tratar doenças proliferativas e/ou distúrbios do sistema imune e para preparar um composto, e, uso de um composto
FI974447A0 (fi) Semikarbatsonit, joilla on keskushermostoaktiivisuutta, ja niitä sisältävät farmaseuttiset valmisteet
DE69728544D1 (de) Totalsynthese von acylfulvenen mit antitumorwirkung
ES552348A0 (es) Procedimiento de preparar agentes anticonvulsivos derivados de aminoacidos
ATE399545T1 (de) Mittel zur verringerung der eigeweidefette
ATE156359T1 (de) Phosphatdiester zur behandlung von proliferativen erkrankungen der epidermis
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
ATE264104T1 (de) Immunmodulierende arzneimittelzusammenstellung
DK526087D0 (da) Antikonvulsive aminosyrederivater
DK498889A (da) Substituerede aromatiske forbindelser med virkning paa centralnervesystemet
EA199900888A1 (ru) Противоревматические средства
DE69123757D1 (de) Epoxysuccinamidsäurederivat
ES2171389T3 (es) Derivados anticonvulsivos de aminoacidos.
DE69014261D1 (de) N-Azabicyclo[3.3.0]octanamide von aromatischen Säuren.
ATE283269T1 (de) 5-(heteroaryl)alkyl)-3-oxo-pyrido(1,2- a)benzimidazol-4-carboxamid (pbi) derivate zur behandlung von störungen des zentralen nervensystems
PT88242A (pt) Processo para a preparacao de eteres e tioeteres tendo actividade terapeutica
ATE220544T1 (de) Neue verwendung von pyrazolopyridinverbindungen
TH20641A (th) 6-[ไทรแอโซลิล[3-(ไทรฟลูออโรเมธิล)เฟนิล]เมธิล]-2-ควิโนลิโนนและ-ควิโนลีนไธโอน

Legal Events

Date Code Title Description
8364 No opposition during term of opposition